318 results on '"Maru, Dipen"'
Search Results
2. Gastric Extent of Tumor Predicts Peritoneal Metastasis in Siewert II Adenocarcinoma
3. Salvage Esophagectomy Definition Influences Comparative Outcomes in Esophageal Squamous Cell Cancers
4. Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy
5. Modified En Bloc Esophagectomy Compared With Standard Resection After Neoadjuvant Chemoradiation
6. A Gold Standard-Derived Modular Barcoding Approach to Cancer Transcriptomics
7. Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer
8. Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases
9. An analysis of research biopsy core variability from over 5000 prospectively collected core samples
10. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma
11. Identification of Colorectal Cancer Cell Stemness from Single-Cell RNA Sequencing
12. Outcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinoma
13. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
14. HER2 Confers Resistance to Foretinib Inhibition of MET-Amplified Esophageal Adenocarcinoma Cells
15. ANPEP/CD13 Expression as a Marker of Lymphovascular Invasion and Survival in Esophageal Adenocarcinoma
16. Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study
17. Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis
18. Radiomics predicts clinical outcome in primary gastroesophageal junction adenocarcinoma treated by chemo/radiotherapy and surgery
19. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
20. Exploratory study of macrophage polarization and spatial distribution in colorectal cancer liver metastasis: a pilot study
21. Author Correction: TP53 loss creates therapeutic vulnerability in colorectal cancer
22. Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients
23. Immunotherapy response evaluation with magnetic resonance elastography (MRE) in advanced HCC
24. Abstract CT148: Efficacy, safety, and biomarker analysis of combined MEK (Cobimetinib) and PD-L1 (Atezolizumab) inhibition (COTEZO) in advanced small bowel adenocarcinoma (SBA)
25. Abstract 77: Recapitulating metastatic colorectal cancer in somatic mutation models for investigating the tumor immune microenvironment in minimal residual disease
26. Gastric Extent of Tumor Predicts Peritoneal Metastasis in Siewert II Adenocarcinoma
27. Endoscopic Ultrasound Estimates for Tumor Depth at the Gastroesophageal Junction Are Inaccurate: Implications for the Liberal Use of Endoscopic Resection
28. Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial
29. Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease
30. Abstract IA004: Targeting STAT3 with TTI-101, an oral small molecule, to prevent colorectal and hepatocellular cancer
31. Abstract A023: Influence of pre-diagnosis obesity and post-diagnosis aspirin use on survival from stage IV colorectal cancer
32. Abstract PR005: Outcomes in colitis-associated metastatic colorectal cancer and intersection with early-onset and signet ring cell carcinoma
33. A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer
34. Signet Ring Cells in Esophageal Adenocarcinoma Predict Poor Response to Preoperative Chemoradiation
35. Association of Prediagnosis Obesity and Postdiagnosis Aspirin With Survival From Stage IV Colorectal Cancer
36. Endothelial Cells Promote the Colorectal Cancer Stem Cell Phenotype through a Soluble Form of Jagged-1
37. The consensus molecular subtypes of colorectal cancer
38. Salvage Esophagectomy After Failed Definitive Chemoradiation for Esophageal Adenocarcinoma
39. TP53 loss creates therapeutic vulnerability in colorectal cancer
40. Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: Significance of microscopically positive circumferential radial margins
41. Does the Timing of Esophagectomy After Chemoradiation Affect Outcome?
42. PD-L1 expression and overall survival in Asian and western patients with gastric cancer
43. Improved Long-Term Outcome With Chemoradiotherapy Strategies in Esophageal Cancer
44. Pathologic T0N1 Esophageal Cancer After Neoadjuvant Therapy and Surgery: An Orphan Status
45. Author Correction: Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
46. Anti-phosphorylated histone H3 expression in Barrett's esophagus, low-grade dysplasia, high-grade dysplasia, and adenocarcinoma
47. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma
48. MicroRNA-196a Is a Potential Marker of Progression during Barrett's Metaplasia-Dysplasia-Invasive Adenocarcinoma Sequence in Esophagus
49. CTIM-04. BIOMARKER IMMUNE CORRELATES IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED WITH ATEZOLIZUMAB IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION
50. Implications of Intratumor Heterogeneity on Consensus Molecular Subtype (CMS) in Colorectal Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.